These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15109542)
1. Domains involved in ETO and human N-CoR interaction and ETO transcription repression. Wang J; Wang M; Liu JM Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542 [TBL] [Abstract][Full Text] [Related]
2. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation. Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665 [TBL] [Abstract][Full Text] [Related]
3. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795 [TBL] [Abstract][Full Text] [Related]
4. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. Lausen J; Cho S; Liu S; Werner MH J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655 [TBL] [Abstract][Full Text] [Related]
5. ETO interacting proteins. Hug BA; Lazar MA Oncogene; 2004 May; 23(24):4270-4. PubMed ID: 15156183 [TBL] [Abstract][Full Text] [Related]
6. A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription. Wei Y; Liu S; Lausen J; Woodrell C; Cho S; Biris N; Kobayashi N; Wei Y; Yokoyama S; Werner MH Nat Struct Mol Biol; 2007 Jul; 14(7):653-61. PubMed ID: 17572682 [TBL] [Abstract][Full Text] [Related]
7. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. McGhee L; Bryan J; Elliott L; Grimes HL; Kazanjian A; Davis JN; Meyers S J Cell Biochem; 2003 Aug; 89(5):1005-18. PubMed ID: 12874834 [TBL] [Abstract][Full Text] [Related]
8. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358 [TBL] [Abstract][Full Text] [Related]
9. Multiple regions of ETO cooperate in transcriptional repression. Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306 [TBL] [Abstract][Full Text] [Related]
10. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Wang J; Saunthararajah Y; Redner RL; Liu JM Cancer Res; 1999 Jun; 59(12):2766-9. PubMed ID: 10383127 [TBL] [Abstract][Full Text] [Related]
12. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
13. [Determination of ETO interaction domain within nuclear receptor co-repressor]. Wang M; Hao C; Tang K; Xing H; Tian Z; Zhang Y; Wang J Zhonghua Xue Ye Xue Za Zhi; 2002 Dec; 23(12):621-3. PubMed ID: 12667342 [TBL] [Abstract][Full Text] [Related]
14. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Huynh KD; Bardwell VJ Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158 [TBL] [Abstract][Full Text] [Related]
15. Oligomerization of ETO is obligatory for corepressor interaction. Zhang J; Hug BA; Huang EY; Chen CW; Gelmetti V; Maccarana M; Minucci S; Pelicci PG; Lazar MA Mol Cell Biol; 2001 Jan; 21(1):156-63. PubMed ID: 11113190 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR. Olsson A; Olsson I; Dhanda RS Biochim Biophys Acta; 2008 Oct; 1779(10):590-8. PubMed ID: 18586123 [TBL] [Abstract][Full Text] [Related]
17. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037 [TBL] [Abstract][Full Text] [Related]
18. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro. Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925 [TBL] [Abstract][Full Text] [Related]
19. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor. Lutz M; Baniahmad A; Renkawitz R Biochem Soc Trans; 2000; 28(4):386-9. PubMed ID: 10961925 [TBL] [Abstract][Full Text] [Related]
20. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells. Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]